Levetiracetam
Product Images NDC 67046-421

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 67046-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2cd73426-figure-01 (2cd73426 Figure 01)

FDA Label Image

2cd73426-figure-02 (2cd73426 Figure 02)

FDA Label Image

2cd73426-figure-03 (2cd73426 Figure 03)

FDA Label Image

2cd73426-figure-04 (2cd73426 Figure 04)

2cd73426-figure-04 (2cd73426 Figure 04)
This is a statistical report on the percentage of patients involved in a clinical trial comparing the effectiveness of a placebo (with a label of H=104) versus Levetiracetam 3000 mg/day (N=180) in the treatment of a certain condition. The percentage of patients in each group is listed, with 5% in the first group, 104% in the second group, and 39.4% in an unspecified group. There is not enough context to understand the meaning of the 104% value, so further information is necessary.*
FDA Label Image

2cd73426-figure-05 (2cd73426 Figure 05)

2cd73426-figure-05 (2cd73426 Figure 05)
This is a table or chart displaying two percentage values: 19.6% and 446%. There is also reference to placebo and a sample size of 97, though it is not clear what the two percentage values refer to.*
FDA Label Image

2cd73426-figure-06 (2cd73426 Figure 06)

FDA Label Image

2cd73426-figure-07 (2cd73426 Figure 07)

FDA Label Image

2cd73426-figure-08 (2cd73426 Figure 08)

2cd73426-figure-08 (2cd73426 Figure 08)
This text is a mathematical equation used in the medical field to calculate creatinine clearance (Cle) in female patients based on their weight and serum creatinine levels. The equation cannot be fully understood without additional context.*
FDA Label Image

2cd73426-figure-10 (2cd73426 Figure 10)

2cd73426-figure-10 (2cd73426 Figure 10)
This is a package insert for Levetiracetam which includes information such as the usual dosage and storage instructions. The medication comes in the form of 500mg film-coated tablets and is controlled by prescription. The lot number and expiration date are given along with the identification code for the pill. This medication was packaged by a Contract Pharmacy located in Warrington, PA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.